SCHEDULE 14A
                                 (Rule 14a-101)

                  INFORMATION REQUIRED IN INFORMATION STATEMENT
                            SCHEDULE 14A INFORMATION

        Information Statement Pursuant to Section 14(a) of the Securities
                    Exchange Act of 1934 (Amendment No. ___)

Filed by the registrant [X]
Filed by a party other than the registrant [ ]

Check the appropriate box:

     [ ]  Preliminary Information Statement
                                            [ ]  Confidential, for use of
                                                 the Commission only (as
                                                 permitted By Rule 14a-6(e)(2)).
     [ ]  Definitive proxy statement.
     [ ]  Definitive additional materials.
     [X]  Soliciting material under Rule 14a-12.


                               RTIN HOLDINGS, INC.
                (Name of Registrant as Specified in its Charter)

    ________________________________________________________________________
    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (check the appropriate box):
     [ ]  No fee required.
     [ ]  Fee  computed on table below per Exchange  Act Rules  14a-6(i)(1)  and
          0-11.
          1)   Title of each class of securities to which transaction applies:
          2)   Aggregate number of securities to which transaction applies:
          3)   Per unit price or other underlying value of transaction  computed
               pursuant  to  Exchange  Act Rule 0-11 (set forth  amount on which
               filing fee is calculated and state how it was determined):
          4)   Proposed maximum aggregate value of transaction:
          5)   Total fee paid:
     [ ]  Fee paid previously with preliminary materials.
     [ ]  Check box if any part of the fee is offset as provided by Exchange Act
          Rule 0-11(a)(2) and identify the filing for which the offering fee was
          paid   previously.   Identify  the  previous  filing  by  registration
          statement number, or the Form or Schedule and the date of the filing.
          1)   Amount previously paid:
          2)   Form, Schedule or Registration Statement No.:
          3)   Filing Party:
          4)   Date Filed:






RTIN HOLDINGS



                                              
Contact: Curtis Swanson                          or Yvonne L. Zappulla
         President and CEO                          Managing Director
         RTIN Holdings, Inc.                        Wall Street Investor Relations Corp.
         903-295-6800                               212-714-2385
         investorrelations@rtinholdings.com         Yvonne@WallStreetIR.com




          RTIN Holdings Proposes New Name: Safescript Pharmacies, Inc.

                       New name reflects Company's new era


Longview, TX - (PRNewsWire)-October  8, 2003 RTIN Holdings, Inc. (OTC BB: RTNH),
a medical  communications and technology company,  announced today that it plans
to  change  its name to  Safescript  Pharmacies,  Inc.  to  better  reflect  its
leading-edge  digital,  acute care prescription  writing and delivery technology
business.

The name change and new corporate  identity  follow the completion of a two-year
sweeping  corporate  overhaul.  The  Company  has  embraced  a highly  effective
digitally-based acute care pharmacy model and has completely disengaged from any
of its previous  holding-company  operations  and  structure.  Over the past six
months,  the Company announced a new executive team led by Curtis Swanson,  CEO;
Steve Cavender,  CFO; David Lee, VP - Technology and Dale Barton,  VP - Pharmacy
Operations.

"Our name change  marks the  culmination  of a successful  transition  towards a
potentially  highly  profitable  and  consistent  new  business  model  that has
extraordinary  growth potential and the discontinuance of all legacy operations.
Each of us in the company  feels  privileged  to be part of what we believe is a
new  era  in the  prescription  delivery  industry.  With  our  name  change  to
Safescript  Pharmacies,  Inc.,  we  intend  to send a clear  signal  that we are
galvanized  and focused on defining our business  within the  parameters  of the
pharmaceutical sector," commented Curtis Swanson, CEO of RTIN.


The Preliminary Solicitation of Written Consents filed today with the Securities
and  Exchange  Commission  by the Board of  Directors of RTIN relates to written
consent by a majority of the  shareholders of the Company to amend the Company's
Articles  of  Incorporation  to  increase  the  authorized  capital of RTIN from
25,000,000  shares  of common  stock to  50,000,000  shares of common  stock and
approve "Safescript  Pharmacies,  Inc." as the new name of the company.  Written
consents  will be  effective  November  17,  2003  regardless  of when  they are
received by the Company. If approved by shareholders, the increase in authorized
capital  and new name  would  become  effective  upon  filing  of the  necessary



documentation  with the  Secretary  of State of the  State of Texas  immediately
following  approval by the  shareholders.  A new CUSIP number and trading symbol
will be  assigned  following  the  effective  date of the name  change.  Swanson
continues,  "There is a new paradigm taking place in prescription  delivery.  We
have the  potential  to set new  standards  for the  industry  with our level of
customer  service,  creating a win-win for all  participants in the system.  Our
wireless,  digital pharmacy system optimizes care for the patient, time and cost
savings  for  the  physicians,  and  offers  a  more  profitable  and  rewarding
experience  for  the  pharmacist.  Our  goal is to  create  an  environment  for
continued  innovation  and assure the growth and success for our Company and its
shareholders for many years to come."

As of October 8, 2003, the Company  operates eight  Company-owned  pharmacies in
two states.  Four licensees of the RTIN  technology  operate  pharmacies in four
additional states.


About RTIN Holdings, Inc.
RTIN  Holdings,   Inc.  is  a  public   holding   company  with  four  operating
subsidiaries,   Safe  Med  Systems,   Inc.,  MedEx  Systems,   Inc.,  Safescript
Pharmacies,  Inc. and Pegasus Pharmacies,  Inc. Safe Med Systems, Inc. and MedEx
Systems,  Inc.  are medical  communications/technology  companies  that  provide
state-of-the-art,  prescription  units loaded with  patent-pending  software and
secure, broadband wireless technology.  Safescript Pharmacies,  Inc. and Pegasus
Pharmacies,  Inc. are the preferred retail pharmacy provider that specializes in
filling  prescriptions  generated  by the Safe Med  Systems  and  MedEx  Systems
technology.   For   additional   information   please   visit  our  websites  at
www.rtinholdings.com and www.safemedinc.com


About the Solicitation of Written Consents
Shareholders  should read the  Solicitation  of Written Consent when they become
available  because it contains  important  information  relating to the proposed
amendments and RTIN. The  Solicitation of Written Consent may be obtained,  when
it becomes  available,  by any  shareholder by contacting the RTIN. In addition,
preliminary  soliciting  materials  and  other  relevant  documentation  may  be
obtained  free  from  the  Securities  and  Exchange   Commission  web  site  at
www.sec.gov.


Certain  statements  in this  news  releases  may  constitute  "forward-looking"
statements  within the meaning of section 21E of the Securities and Exchange Act
of 1934.  The Company  believes  that its  expectations,  as  expressed in these
statements  are  based  on  reasonable   assumptions  regarding  the  risks  and
uncertainties  inherent in achieving those  expectations.  These  statements are
not,  however,  guarantees of future  performance  and actual results may differ
materially.  Some of the factors that may affect the forward looking  statements
in this news release are the rate of acceptance  of new versions of  proprietary
software, the availability of personnel to present new software to users and the
availability and  functionality of competitive  systems.  Other risk factors are
listed in the most recent Annual  Report on Form 10-KSB and Quarterly  Report on
Form  10-QSB  filed  with  the   Securities   and  Exchange   Commission.   Such
forward-looking  statements  involve risks,  uncertainties,  which may cause the
actual results, performance, or achievement expressed or implied to differ.


                                      # # #